API5 and neoplasm: Interestingly, a peptide preventing API5 interaction with its partners has been demonstrated to potentiate E2F1-induced apoptosis in tumor cells [65], and supporting the inhibition of API5 function as a new strategy to induce E2F1-dependant cell death might offer a possible mechanism for antitumor exploitation (see below).